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Abstract 
Background: How cells respond and adapt to environmental changes, such as nutrient flux, remains poorly 
understood. Evolutionarily conserved nutrient signaling cascades can regulate chromatin to contribute to genome 
regulation and cell adaptation, yet how they do so is only now beginning to be elucidated. In this study, we provide 
evidence in yeast that the conserved nutrient regulated target of rapamycin complex 1 (TORC1) pathway, and the 
histone H3N-terminus at lysine 37 (H3K37), function collaboratively to restrict specific chromatin-binding high mobil-
ity group box (HMGB) proteins to the nucleus to maintain cellular homeostasis and viability.
Results: Reducing TORC1 activity in an H3K37 mutant causes cytoplasmic localization of the HMGB Nhp6a, organelle 
dysfunction, and both non-traditional apoptosis and necrosis. Surprisingly, under nutrient-rich conditions the H3K37 
mutation increases basal TORC1 signaling. This effect is prevented by individual deletion of the genes encoding 
HMGBs whose cytoplasmic localization increases when TORC1 activity is repressed. This increased TORC1 signaling 
also can be replicated in cells by overexpressing the same HMGBs, thus demonstrating a direct and unexpected role 
for HMGBs in modulating TORC1 activity. The physiological consequence of impaired HMGB nuclear localization is an 
increased dependence on TORC1 signaling to maintain viability, an effect that ultimately reduces the chronological 
longevity of H3K37 mutant cells under limiting nutrient conditions.
Conclusions: TORC1 and histone H3 collaborate to retain HMGBs within the nucleus to maintain cell homeostasis 
and promote longevity. As TORC1, HMGBs, and H3 are evolutionarily conserved, our study suggests that functional 
interactions between the TORC1 pathway and histone H3 in metazoans may play a similar role in the maintenance of 
homeostasis and aging regulation.
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Background
In response to changing environmental conditions, such 
as nutrient fluxes or the presence of stress, eukaryotic cells 
adapt by modulating chromatin structure and their gene 
expression programs [1]. Chromatin alterations are largely 
controlled by DNA methylation, histone post-transla-
tional modifications, ATP-dependent nucleosome remod-
eling, histone chaperones, and histone variants [2, 3]. 
Oftentimes, the changes made to chromatin and the sub-
sequent regulation of key transcriptional programs is the 
endpoint for such environmentally responsive chromatin 
pathways. In some cases, however, chromatin changes 
function not as an endpoint but instead they propagate 
this information to regulate additional nuclear and/or 
cytoplasmic processes [1]. Thus, signaling to and from 
chromatin impacts a wide range of biological activities. 
While the mechanisms controlling chromatin structure 
continue to be elucidated, how environmental informa-
tion is transferred to the chromatin and transcription reg-
ulatory apparatus, and its impact on chromatin’s signaling 
functions, remains poorly understood.
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The target of rapamycin (TOR) pathway is a highly 
conserved signaling cascade essential for cell growth, 
proliferation, and suppression of stress responses [4, 5]. 
TOR consists of two distinct subpathways composed of 
TOR complex 1 (TORC1) and TOR complex 2 (TORC2). 
Environmental nutrients, growth factors/mitogens, 
and energy specifically activate TORC1, which then 
stimulates numerous downstream transcriptional and 
translational processes regulating anabolism [5]. Simul-
taneously, TORC1 suppresses catabolic stress responses 
such as autophagy [4, 5]. Budding yeast TORC1 consists 
of either the Tor1 or Tor2 kinase and the Kog1, Lst8, and 
Tco89 subunits. While TORC1 activity is essential, yeast 
lacking the Tor1 or Tco89 subunits is viable. However, 
these mutants exhibit hypersensitivity to agents that sup-
press TORC1, including the specific inhibitor rapamycin, 
nutrient starvation, and other environmental stresses [4].
Yeast TORC1 is activated predominantly by nitro-
gen, in particular amino acids, which is registered by the 
EGO complex. EGO consists of the Ego1-3 subunits, as 
well as the Rag GTPases Gtr1 and Gtr2. EGO resides in 
the vacuole membrane where it senses luminal amino 
acid accumulation and then activates vacuole-localized 
TORC1 in response [6]. The V-ATPase complex, which 
is the resident proton pump in the vacuole membrane, 
also interacts with EGO to stimulate TORC1 as well 
[7]. Active TORC1 then either phosphorylates down-
stream effectors to mediate its biological functions, or 
it activates some processes directly, including transcrip-
tion by RNA polymerase I and III (Pol I and Pol III) [8, 
9]. TORC1 downstream effector pathways include direct 
phosphorylation of the Sch9 kinase to promote riboso-
mal biogenesis, as well as activation of the Ypk3 kinase to 
phosphorylate ribosomal protein S6 [10, 11]. TORC1 also 
phosphorylates the regulatory factor Tap42 which binds 
to PP2A- and PP2A-like phosphatases. Tap42 seques-
ters these enzymes onto the vacuole surface and restricts 
their access to substrates, many of which regulate nutri-
ent stress responses [4, 12, 13]. Therefore, TORC1 relays 
upstream environmental information to the downstream 
biochemical machinery controlling cell growth and 
proliferation.
Emerging studies also implicate TORC1 in chromatin 
regulation, suggesting TORC1 may mediate environ-
ment–epigenome interactions. For example, the yeast 
Esa1 histone acetyltransferase is recruited in a TORC1-
regulated fashion to ribosomal protein (RP) genes to 
promote histone acetylation and gene transcription [14]. 
TORC1 also regulates histone H3 lysine 56 acetylation 
(H3K56ac), and this process is important for TORC1-
dependent transcription of the ribosomal DNA (rDNA) 
loci by Pol I and ribosomal RNA co-transcriptional pro-
cessing [15]. Further studies of yeast rDNA regulation 
have determined that rDNA copy number increases in 
a TORC1-dependent manner which is a process that is 
actively opposed by the sirtuins Sir2, Hst3, and Hst4 [16]. 
Thus, the eukaryotic genome adaptively alters gene copy 
number in response to environmental stimuli through 
a mechanism involving TORC1-dependent epigenetic 
regulation.
Recently, we sought to identify histone H3 or H4 resi-
dues that exhibited genetic interactions with TORC1 and 
as such might function in TORC1-regulated epigenetic 
mechanisms. Using a rapamycin-based chemical genom-
ics screen, we determined that a mutation of H3 lysine 
37 (H3K37) was synthetically lethal when combined 
with decreased TORC1 signaling [17]. Because H3K37 
regulates high mobility group box (HMGB) association 
to chromatin, we examined the fate of HMGB proteins 
in the H3K37 mutant. Our initial studies found that an 
H3K37 mutant disrupted chromatin binding of the yeast 
HMGB protein Nhp10, causing a significant fraction of 
Nhp10 to localize to the cytosol when TORC1 signaling 
was reduced. Increased Nhp10 cytosolic accumulation 
correlated with massive cell death in the H3K37 mutant 
when TORC1 was inhibited [17]. However, whether 
decreased chromatin binding by Nhp10 or other HMGBs 
was the proximal cause of cell death under these condi-
tions was not defined.
Besides histones, HMG proteins are the next most 
abundant protein component of chromatin [18]. The 
HMGB family is evolutionarily conserved from yeast to 
humans, and they function in all genome-regulatory pro-
cesses by binding to minor groove DNA to create altered 
DNA structures [18]. While some HMGB domain-con-
taining transcription factors bind DNA in a sequence-
specific fashion, non-transcription factor HMGBs bind in 
a sequence-independent, but chromatin context-depend-
ent manner. HMGBs also have additional regulatory roles 
independent of DNA binding. For instance, necrotic 
mammalian cells release the prototypical HMGB factor, 
HMGB1, into the extracellular milieu. This extracellular 
HMGB1 stimulates inflammatory processes by bind-
ing to Toll-like and RAGE receptors on innate immune 
cells [18]. Additionally, cytosolic HMGB1 has impor-
tant roles in regulating mitochondrial function and cel-
lular metabolism [19, 20]. Intriguingly, in  vitro binding 
assays using HMGB1 and nucleosomal DNA demon-
strate that HMGB1 selectively makes contacts with the 
H3 tail at multiple positions, including histone H3 lysine 
36 (H3K36) and H3K37 [21, 22]. Although performed 
in  vitro, these studies reinforce the possibility that 
the functional genetic interactions identified between 
TORC1 and H3K37 involve HMGB chromatin binding.
The mechanisms underlying the connections between 
HMGB chromatin binding and TORC1 have remained 
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unclear. In this study, we provide further evidence that 
TORC1 and H3K37 function synergistically to retain 
specific HMGBs in the nucleus. Impairment of both 
TORC1 signaling and H3K37 causes these HMGBs to 
accumulate in the cytoplasm. Once cytoplasmic, these 
HMGBs induce both an atypical mitochondrial-depend-
ent apoptosis and necrosis caused by vacuole dysregula-
tion and impaired pH homeostasis. Surprisingly, we find 
that either reduced HMGB chromatin binding or HMGB 
dysregulation increases TORC1 signaling which severely 
curtails the chronological aging process. These results 
demonstrate that TORC1 signaling and H3K37 act to 
maintain cellular homeostasis and promote longevity by 
restricting HMGB localization to the nucleus.
Results
Histone H3K37 disruption differentially affects the nuclear 
localization of specific HMGBs
Our rapamycin-based genetic screens determined that 
H3K37A sensitized cells to reduced TORC1 activity 
[17]. This effect is solely specific for H3K37A as muta-
tion of flanking residues, including the adjacent methyl-
ated H3K36, has no effect (Fig. 1a). H3K37A rapamycin 
sensitivity is independent of H3K37 post-translational 
modification since both H3K37R and H3K37Q restore 
growth on rapamycin plates, albeit H3K37Q mutants 
do have a modest growth advantage under these condi-
tions (Fig. 1b). To confirm these results are not due solely 
to the histone H3/H4 library background, we utilized a 
well-characterized histone shuffle strain and shuffled into 
it vectors expressing H3 wild type (H3WT), H3K37A, 
or H3K37R as the sole source of histone H3 [23]. These 
cells, along with the H3WT and H3K37A derived from 
the library, were spotted to control or 10 nM rapamycin 
plates. The shuffle strain expressing H3WT is consider-
ably more rapamycin sensitive than the H3WT from the 
library; however, in the shuffle background the H3K37A 
is still sensitive to TORC1 inhibition, while the H3K37R 
restores growth (Fig.  1c). These results suggest that the 
TORC1 phenotype caused by H3K37A is not due solely 
to loss of electrostatic charge or post-translational modi-
fication (since both H3K37R and H3K37Q rescue), but 
it is instead due to the impairment of a protein–protein 
contact at H3K37 due to the incorporation of the small 
hydrophobic alanine at this position. Because both argi-
nine and glutamine have the potential to form electro-
static or polar interactions, their incorporation at H3K37 
likely restores this disrupted function.
The histone H3N-terminus has several sites of post-
translational modifications that contribute to a diverse 
array of chromatin functions, including gene transcrip-
tion [24]. To address the interaction of the H3N-terminus 
with the TORC1 pathway, we compared the rapamycin 
sensitivity of H3WT, H3K37A, and an H3N-terminal 
truncation mutant (H3Δ1-32) lacking the majority 
of post-translationally modified N-terminal residues. 
H3Δ1-32-expressing cells exhibit increased sensitivity to 
TORC1 inhibition relative to H3WT; however, they still 
retain the ability to grow under these conditions unlike 
the complete growth impairment detected with H3K37A 
(Fig.  1d). The growth inhibition caused by rapamycin 
in H3K37A is due solely to TORC1 suppression as cells 
expressing a rapamycin-resistant TOR1-1 vector grow 
comparable to TOR1-1-expressing H3WT (Fig. 1e) [25]. 
Therefore, while post-translationally modifiable posi-
tions on the H3N-terminus likely contribute to mediating 
some sensitivity to TORC1 inhibition, H3K37 provides 
an absolutely essential, highly specific function in this 
regard.
We previously demonstrated that extended TORC1 
inhibition in H3K37A caused cell death by necrosis [17]. 
To gauge how quickly cell death occurs in H3K37A, and 
to determine whether it is solely necrotic or whether it 
may encompass both necrosis and apoptosis at early 
stages, we mock- or 20  nM rapamycin-treated H3WT 
and H3K37 for increasing lengths of time. Cells were then 
stained with YO-PRO-1 (which stains early apoptotic 
cells) and propidium iodide (PI, which stains necrotic 
cells) and analyzed by flow cytometry [26]. No cell death 
occurred in mock- or rapamycin-treated H3WT or 
mock-treated H3K37A over the course of the experiment 
(Fig. 1f ). After TORC1 inhibition in H3K37A, negligible 
apoptosis (Yo+ PI−) and necrosis (Yo+ PI+) occurred 
at 60 min, while both were detected by 90 min (Fig. 1f ). 
These results indicate that decreased TORC1 signaling in 
H3K37A causes cytotoxicity through both apoptosis and 
necrosis and that this does not begin significantly until 
after 60-min post-TORC1 inhibition.
H3K37A impairs Nhp10 chromatin binding, while 
TORC1 inhibition exacerbates this effect to cause Nhp10 
cytoplasmic accumulation [17]. Since HMGB deregu-
lation is cytotoxic [17], we speculated that TORC1 
inhibition results in H3K37A cytotoxicity by causing 
HMGB cytoplasmic accumulation. To test this, we gen-
erated a series of reporter strains expressing genomi-
cally integrated EGFP reporter tags at the loci encoding 
the HMGBs ABF2, HMO1, IXR1, and NHP6A in H3WT 
and H3K37A cells. Live cell confocal microscopy of 
mock treated or cells treated for 1  h with 20  nM rapa-
mycin revealed highly specific effects on HMGB cellu-
lar localization. Nhp6a was exclusively localized to the 
nucleus in H3WT independent of TORC1, while it was 
mostly nuclear in H3K37A mock-treated cells. However, 
in H3K37A TORC1 inhibition caused a fraction of Nhp6a 
to become cytosolic (Fig. 2a, b). These data were in stark 
contrast to those found for Ixr1. In H3WT cells, Ixr1 
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remained nuclear in both mock- and rapamycin-treated 
cells. However, in mock-treated H3K37A, Ixr1 accumu-
lated in the cytoplasm which was reversed when TORC1 
signaling was diminished (Fig. 2c, d). The HMGB Abf2 is 
used to demarcate mitochondria as it localizes exclusively 
to this organelle [27]. As expected, Abf2 localization 
remained in the cytoplasm in either H3WT or H3K37A 
irrespective of TORC1 activity, thus demonstrating the 
nuclear-specific effects of the histone mutation (Addi-
tional File 1: Figure S1a). Interestingly, the mitochondria 
in the TORC1-inhibited H3K37A cells appear to be more 
elongated relative to the rapamycin-treated H3WT cells, 
Fig. 1 H3K37 is required for cell death suppression in TORC1-inhibited cells independent of histone modification status. a Spotting assay with 
H3WT and the indicated histone H3 mutants on control plates or plates containing 20 nM rapamycin. b As in a except a mutant that restores elec-
trostatic charge (H3K37R) or mimics constitutive acetylation (H3K37Q) was analyzed. c H3WT and H3K37A mutants from a were spotted in parallel 
with a histone shuffle strain containing as the sole source of histone H3 either H3WT, H3K37A, or H3K37R. d As in a, except H3WT, H3K37A, and an 
H3 mutant lacking the first 32N-terminal amino acids (H3Δ1-32) were analyzed. e H3WT and H3K37A expressing control vector or vector expressing 
the rapamycin-resistant TOR1-1 allele were spotted to plasmid-selective media (SC-Leu) or media containing 15 nM rapamycin. f H3WT and H3K37A 
cells were mock treated or 20 nM rapamycin treated for the indicated times and then stained with YO-PRO-1 to detect apoptosis (Yo+ PI−) and 
propidium iodide to detect necrosis (Yo+ PI+). Cells were then analyzed by flow cytometry
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suggesting the possibility that increased mitochondrial 
stress may be occurring in these cells (Additional File 
1: Figure S1a). Such an interpretation would be consist-
ent with the increase in apoptotic cell death detected 
in TORC1-inhibited H3K37A cells (Fig.  1f ) since apop-
tosis is a mitochondrial-dependent process [28]. Addi-
tionally, and consistent with our previous study, the 
nuclear localization of the TORC1 transcriptional effec-
tor HMGB, Hmo1, was unaffected under both active and 
reduced TORC1 signaling conditions in both H3WT and 
H3K37A (Additional File 1: Figure S1b) [17]. Therefore, 
H3K37A impairs the nuclear localization of select HMGB 
factors under both normal and reduced TORC1 signaling 
conditions.
Because TORC1 inhibition in H3K37A increased 
Nhp6a-EGFP cytoplasmic localization, which correlated 
with induction of cell death, we analyzed this HMGB 
further. Nhp6a-EGFP strains, along with cells express-
ing Nhp6a-EGFP in an H3K37R background, were cul-
tured to log phase and either mock treated or treated 
with 20 nM rapamycin for 1 h, before analysis by confo-
cal microscopy. As expected, Nhp6a localized exclusively 
Fig. 2 Histone H3 and TORC1 differentially regulate Nhp6a and Ixr1 cellular localization. Confocal microscopy and brightfield images of H3WT and 
H3K37A expressing either Nhp6a-EGFP (a, b) or Ixr1-EGFP (c, d). Cells were mock or 20 nM rapamycin treated for 1 h. The outline of individual cells is 
demarcated by the line trace. The nucleus is indicated by Hoechst (blue) staining. Scale bar indicates 5 μm for all live cell confocal images
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to the nucleus in H3WT regardless of TORC1 activ-
ity, while rapamycin treatment reduced (by ~15  %) the 
nuclear Nhp6a pool in H3K37A (Fig. 3a, b). The H3K37R, 
which restores growth under impaired TORC1 signal-
ing conditions (Fig.  1b, c), completely restored Nhp6a 
nuclear localization (Fig. 3a, b). To unequivocally confirm 
these effects on Nhp6a localization were due solely to 
TORC1 inhibition, we transformed H3WT and H3K37A 
Nhp6a-EGFP-expressing cells with control or rapamycin-
resistant TOR1-1 expression vector. These cells were cul-
tured in selective, nutrient-defined media buffered to pH 
6.5 and then mock or 20 nM rapamycin treated for 2 h 
before confocal microscopy analysis. Consistent with our 
previous results, Nhp6a nuclear localization was unaf-
fected in H3WT expressing control or TOR1-1 expres-
sion vector under either condition (Additional File 1: 
Figure S2a-b). Rapamycin-treated H3K37A cells with 
control vector exhibited increased Nhp6a movement 
to the nuclear periphery and into the cytoplasm, while 
the expression of the rapamycin-resistant TOR1-1 allele 
completely restored Nhp6a nuclear localization (Addi-
tional File 1: Figure S2a-b). This effect correlates with the 
restoration of cell viability as well (Fig. 1e). Nhp6a and its 
paralog Nhp6b are redundant components of the FACT 
histone chaperone [29, 30]. To determine whether rapa-
mycin-induced Nhp6a cytoplasmic localization involved 
FACT, we integrated an EGFP tag at the SPT16 genomic 
locus (a core FACT subunit) in H3WT and H3K37A and 
repeated these experiments. Spt16 remained nuclear in 
both H3WT and H3K37A, irrespective of TORC1 activ-
ity (Fig.  3c). Therefore, H3K37A causes a subpopula-
tion of Nhp6a not affiliated with FACT to localize to the 
cytoplasm when TORC1 activity is limiting, suggesting 
Nhp6a cytoplasmic accumulation may be connected to 
cell death induction.
TORC1 inhibition in H3K37A induces cell death 
through both mitochondrial and vacuole dysfunction
If cytoplasmic localization of any single HMGB induces 
cell death in H3K37A TORC1-inhibited cells, then loss of 
this HMGB may rescue growth of these cells. To test this 
possibility, we deleted five of the seven HMGB encod-
ing genes in both H3WT and H3K37A. We were unable 
to obtain an ABF2 gene deletion for unknown reasons, 
and the NHP6B gene, which encodes the Nhp6a par-
alog, overlaps with an uncharacterized gene, so it was not 
tested. Of the five HMGB deletions examined, only ixr1∆ 
weakly rescued H3K37A growth on rapamycin plates 
(Fig. 4a). Intriguingly, ixr1∆ also resulted in more robust 
growth of H3WT when TORC1 was inhibited (Fig.  4a), 
suggesting its loss provided a generalized growth advan-
tage. These results were surprising since Ixr1 completely 
localizes to the nucleus in H3K37A TORC1-inhibited 
cells (Fig.  2b). To further characterize the mechanism 
involved, we cultured H3WT, H3K37A, and their ixr1∆ 
derivatives to log phase, mock treated or treated with 
20  nM rapamycin for 5.5  h, and then stained cells to 
quantify the population of both apoptotic and necrotic 
cells. We also engineered mitochondria-deficient (ρ°) 
derivatives to determine whether the cell death required 
mitochondria since this organelle regulates apoptosis 
[28]. TORC1 inhibition had no effect on H3WT or its 
derivatives, while it induced both apoptosis and necrosis 
in H3K37A (Fig. 4b). Individual loss of either functional 
mitochondria or ixr1∆ completely abolished apoptosis in 
TORC1-inhibited H3K37A cells, while having negligible 
effects on necrosis (Fig.  4b). This necrosis was not due 
to parallel roles for mitochondria and Ixr1 in cell death 
regulation since H3K37A ixr1∆ ρ° cells exhibited compa-
rable amounts of necrosis relative to individual H3K37A 
ρ° or H3K37A ixr1∆ cells (Fig. 4b).
Both Ixr1 and the HMGB Rox1 repress genes encod-
ing mitochondrial components [31]. To test how spe-
cific the ixr1∆-dependent apoptosis suppression was, 
we repeated the mock and 5.5-h rapamycin treatment 
and compared apoptosis levels in H3WT, H3K37A, and 
either the ixr1∆ or rox1∆ in these backgrounds. TORC1 
inhibition induced apoptosis in H3K37A, which was sup-
pressed by ixr1∆, whereas rox1∆ had no effect (Fig. 4c). 
These results suggest that apoptosis suppression in ixr1∆ 
is likely not due to altered transcription of Ixr1 and Rox1 
co-regulated genes. Therefore, both mitochondria and 
Ixr1 regulate apoptosis in TORC1-limited cells, while 
neither affects the concomitant necrosis that occurs.
Reduced TORC1 activity increases mitochondrial 
function in part because the TORC1 subunit, Lst8, func-
tions in retrograde signaling [32]. Because H3K37A 
rapamycin-induced apoptosis requires mitochondria, 
we investigated whether TORC1 inhibition in H3K37A 
altered retrograde signaling. Log phase cultures of 
H3WT and H3K37A were either mock or 20  nM rapa-
mycin treated for one hour before analyzing expression 
of the retrograde-inducible CIT2 gene [33]. Consistent 
with the increased mitochondrial function that occurs 
when TORC1 is inhibited, CIT2 was upregulated 
approximately tenfold in rapamycin-treated H3WT cells 
compared to control (Fig.  4d). While H3K37A had no 
effect on CIT2 expression in mock-treated cells, CIT2 
was induced to significantly higher levels in rapamy-
cin-treated H3K37A relative to the comparable H3WT 
(Fig.  4d). Since retrograde activation occurs as a con-
sequence of mitochondrial dysfunction, we repeated 
this experiment and stained cells with dihydroethidium 
(DHE) to measure reactive oxygen species (ROS) as an 
indicator of mitochondrial stress. We analyzed the deriv-
ative ixr1∆ and rox1∆ mutants as well. Mock-treated 
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Fig. 3 TORC1 and histone H3 regulate Nhp6a nuclear localization independently of the FACT histone chaperone complex. a Mock or 1-h 20 nM 
rapamycin-treated H3WT, H3K37A, and H3K37R cells expressing Nhp6a-EGFP were analyzed by confocal microscopy. Cell outlines are indicated by 
the line trace. b Quantification of Nhp6a nuclear localization from three independent experiments with the average and standard deviation (SD) 
plotted. One-way ANOVA was performed across all categories which is indicated by the dashed line, while the solid black line indicates the pairwise 
comparison analyzed by Student’s t test. *P < 0.05; **P < 0.01. c. As in a, except cells expressing Spt16-EGFP were analyzed. Brightfield images for  
a and c are in Additional File 1: Figure S3
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H3WT and H3K37A exhibited similar ROS levels, while 
TORC1 inhibition in H3WT did not alter ROS; however, 
rapamycin treatment did induce significantly higher ROS 
in H3K37A (Fig. 4e). Intriguingly, ixr1∆, but not rox1∆, 
completely suppressed this increased ROS which also 
correlated with ixr1∆-dependent suppression of apopto-
sis (Fig. 4b, e). To test whether this ROS caused cell death, 
we transformed H3WT and H3K37A cells with control 
vector or a multicopy vector overexpressing superoxide 
dismutase SOD1, which detoxifies ROS [34]. Surprisingly, 
SOD1 overexpression did not rescue H3K37A growth 
when TORC1 was inhibited (Fig.  4f ). While these data 
demonstrate a role for both mitochondrial dysfunction 
and Ixr1 in regulating TORC1-inhibited H3K37A apop-
tosis, the results suggest ROS suppression alone is insuf-
ficient to restore cell growth.
An ixr1∆, or loss of functional mitochondria, abol-
ished rapamycin-induced H3K37A apoptosis, yet the 
ixr1∆ ρ° did not substantially reduce necrosis (Fig.  4b). 
To determine whether the double mutant enhanced the 
weak growth rescue that the ixr1∆ provided H3K37A 
cells, we spotted these cells from Fig.  4b to control or 
20  nM rapamycin plates. Consistent with our previ-
ous results (Fig.  4a), H3WT ixr1∆ cells grew more 
robustly on rapamycin-containing media (evident by 
larger colony size), whereas H3WT ρ° cells grew more 
poorly (Fig.  4g). Surprisingly, while the H3K37A ixr1∆ 
weakly restored growth, neither the H3K37A ρ° nor the 
H3K37A ixr1∆ ρ° mutant was capable of growth even 
though both suppressed apoptosis (Fig.  4b, c, g). These 
data suggest that mitochondria, while responsible for 
the TORC1-inhibited H3K37A apoptosis, also provide 
a required positive function necessary for cell growth 
under these conditions. To further characterize the 
apoptosis mechanisms involved, we deleted the genes 
encoding mitochondrial-regulated apoptosis effectors, 
including metacaspase (YCA1), endonuclease G (NUC1), 
and apoptosis-inducing factor (AIF1), either individu-
ally or in combination [28]. Intriguingly, none of these 
mutants rescued H3K37A under TORC1-suppressive 
conditions (Fig. 4h). These data demonstrate that TORC1 
inhibition-induced H3K37A apoptosis requires Ixr1 and 
mitochondria, but this apoptosis occurs independently of 
traditional apoptotic effectors and is genetically separable 
from the concurrent necrosis that occurs.
Loss of Ixr1 results in the transcriptional induction 
of many genes involved in cell metabolism and stress 
responses [35]. We considered the possibility that ixr1∆ 
weakly rescued TORC1-inhibited H3K37A cells indi-
rectly due to transcriptional upregulation of normally 
Ixr1-repressed genes. We tested this by transforming 
H3WT and H3K37A cells with a control vector and, for 
H3K37A, individual galactose-inducible vectors express-
ing a subset of Ixr1-repressed genes linked to metabolism 
(MET10, PBI2, GNA1, and GID1) or stress responses 
(STF2, PAI3, TIR1, and TIR3) [35]. We also included a 
galactose-inducible YAP1 expression vector, since Yap1 
induces stress response genes [36]. Of the genes exam-
ined, only TIR1 overexpression weakly rescued H3K37A 
growth on rapamycin plates (Fig. 5a). TIR1 encodes a cell 
wall mannoprotein induced under acid stress conditions 
[37], thus suggesting TORC1 suppression in H3K37A 
may induce an acid stress response to cause cell death. 
We tested this directly by culturing H3WT and H3K37A 
cells to mid-log phase and either mock or 20  nM rapa-
mycin treated for 30  min. Cells were then stained with 
the vacuole-specific dye FM-464 and the pH indicator 
dye 5(6)-CFDA before performing confocal microscopy 
[38, 39]. Under physiological pH, 5(6)-CFDA does not 
significantly fluoresce, but as intracellular pH decreases 
it becomes fluorescent. Mock- and rapamycin-treated 
H3WT, as well as mock-treated H3K37A, exhibited no 
detectable  5(6)-CFDA fluorescence. However, within 
30  min of TORC1 inhibition, significant 5(6)-CFDA 
fluorescence began to accumulate in H3K37A vacuoles 
indicating decreased intravacuolar pH (denotes by white 
arrows, Fig. 5b). This signal accumulated over time only 
in H3K37A, demonstrating that H3K37A TORC1 inhibi-
tion induces rapid vacuole dysfunction and altered pH 
homeostasis (Fig.  5c). To determine whether this intra-
cellular acidification contributes to cell death, H3WT, 
H3K37A, and their ρ° derivatives were spotted to control 
(See figure on previous page.) 
Fig. 4 Histone H3 and TORC1 synergistically suppress both apoptosis and necrosis. a Spotting assay with H3WT, H3K37A, and the indicated HMG 
gene deletions. b Flow cytometry analysis of the indicated strains cultured to log phase and then mock treated or treated with 20 nM rapamycin 
for 5.5 h before staining with YO-PRO-1 and PI. Data are the average and SD of three independent experiments. c As in b except staining was 
performed only with YO-PRO-1 to solely detect apoptotic cells. d cDNA samples from H3WT and H3K37A mock or 20 nM rapamycin treated for 1 h 
were analyzed for CIT2 expression. Data are the average and SD of five independent experiments. e As in b except cells were stained with DHE. The 
average and SD of three independent experiments are presented. f Spotting assay on selective media (SC-Leu) with H3WT and H3K37A carrying 
either a control vector or an SOD1 high copy expression vector (OE). g Spotting assay with H3WT, H3K37A, and their derivatives lacking Ixr1 (ixr1∆), 
functional mitochondria (ρ°), or both. h As in a except genes encoding the indicated apoptotic effectors were deleted either individually or in com-
bination. For all statistical analyses, one-way ANOVA was performed across all categories which is indicated by the dashed line, while the solid black 
lines indicate the specific pairwise comparisons which were analyzed by Student’s t test. *P < 0.05; **P < 0.01; ***P < 005
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and rapamycin plates which were either non-buffered 
or buffered to pH 6.0 with MES. Rapamycin alone pre-
vented H3K37A growth; however, pH buffering weakly 
rescued H3K37A growth (Fig.  5d). Surprisingly, the 
H3K37A ρ° mutant grew more poorly under these con-
ditions than did the H3K37A mutant (Fig. 5d). Our data 
Fig. 5 TORC1 and histone H3 prevent cell death through vacuole dysfunction and altered pH homeostasis. a H3WT and H3K37A transformed with 
control vector or the indicated galactose-inducible expression vectors were spotted to the indicated plates. b H3WT and H3K37A were cultured 
to log phase and then mock or 20 nM rapamycin treated for 30′ before staining with FM-464 (red, stains vacuole membrane) and 5(6)-CFDA (green 
upon acidification). Arrows indicate cells where significant fluorescence is detectable. c Experiment was performed as in b, and cells were sampled, 
stained, and analyzed by flow cytometry at the indicated times post-rapamycin treatment. Data are the average and SD of 3 independent experi-
ments. d H3WT, H3K37A, and ρ° derivatives in these backgrounds were spotted to control synthetic complete (SC) plates or 20 nM rapamycin SC 
plates that were either non-buffered or buffered to pH 6.0 with MES
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suggest that while mitochondria may regulate apoptosis 
in H3K37A cells, they also likely provide a positive meta-
bolic function required for cell growth when intracellu-
lar pH decreases. These results also demonstrate that the 
necrosis induced by TORC1 inhibition in H3K37A cells 
is caused by impaired vacuole homeostasis and pH dys-
regulation. The ability of ixr1∆ to weakly rescue H3K37A 
is therefore most likely indirectly caused by the increased 
expression of acid stress response genes such as TIR1 
[35].
Impaired HMGB nuclear localization dysregulates TORC1 
signaling and limits chronological longevity
The profound sensitivity of H3K37A cells to TORC1 
inhibition suggests that they are over reliant on TORC1 
activity to maintain viability. To explore this concept 
in greater mechanistic detail, we assessed the strength 
of TORC1 signaling in H3WT and H3K37A cells cul-
tured in nutrient-rich media to mid-log phase before 
mock treating or treating with 20  nM rapamycin for 
30  min. Cell extracts were prepared, and TORC1 activ-
ity was monitored by assessing phosphorylation of ribo-
somal protein S6 (phosphoS6) [11]. Surprisingly, the 
mock-treated H3K37A mutant exhibited substantially 
increased TORC1 activity relative to the comparable 
mock-treated H3WT, while rapamycin treatment sup-
pressed TORC1 to approximately the same extent in both 
H3WT and H3K37A (Fig.  6a). To determine whether 
the elevated TORC1 signaling in H3K37A was due to 
HMGB dysregulation, we analyzed TORC1 activity in 
H3WT and H3K37A, as well as their nhp6a∆ or hmo1∆ 
derivatives. We also analyzed nhp10∆ since its chro-
matin binding and nuclear localization are impaired in 
H3K37A similar to that detected for Nhp6a [17]. In the 
H3WT background, the nhp6a∆, nhp10∆, and hmo1∆ 
decreased the overall level of TORC1 signaling relative 
to H3WT, suggesting these HMGBs affect basal TORC1 
activity in cells with wild-type chromatin (Fig.  6b). 
Importantly, nhp6a∆ and nhp10∆, but not hmo1∆, signif-
icantly reduced TORC1 signaling in H3K37A to H3WT 
levels (Fig.  6b). This observation is consistent with the 
cytoplasmic accumulation of both Nhp6a (Figs. 2a, 3a, b) 
and Nhp10 [17], but not Hmo1 (Additional File 1: Figure 
S1b) in TORC1-inhibited H3K37A cells. To test whether 
HMGB dysregulation directly increases TORC1 activity, 
we transformed H3WT cells with control or galactose-
inducible HA-tagged NHP6A or HMO1 expression vec-
tors, cultured them to log phase in raffinose media, and 
induced them with galactose for 20 min before preparing 
cell extracts and analyzing phosphoS6. Hmo1 expression 
caused a minor, while Nhp6a expression caused a much 
greater, increase in phosphoS6 (Fig.  6c). These results 
demonstrate that HMGB dysregulation, due to impaired 
chromatin association or deregulated HMGB expression, 
stimulates TORC1 signaling.
We next examined whether HMGB dysregulation in 
H3WT mimicked the same defect in vacuolar pH homeo-
stasis that occurred in H3K37A upon TORC1 limitation. 
We initially attempted a galactose induction utilizing 
our HMGB expression vectors coupled with 5(6)-CFDA 
staining and flow cytometry analysis. However, galactose 
treatment caused cell acidification even in vector con-
trol cells which confounded data interpretation (data not 
shown). To bypass this issue, we repeated the experiment 
in cells cultured solely to log phase in raffinose media 
since we have found these vectors exhibit low level, leaky 
HMGB expression. Log phase cells were stained with 
5(6)-CFDA and analyzed by flow cytometry (Fig.  6d). 
Expression of either Nhp6a or Hmo1 increased overall 
mean fluorescence intensity of the population (Fig.  6e), 
as well as the total percentage of cells falling within the 
acidified category (Fig.  6f, cell population quantified is 
indicated by the horizontal bracket in Fig. 6d). These data 
demonstrate that HMGB dysregulation in cells with wild-
type chromatin replicates the increased vacuolar acidifi-
cation detected in TORC1-inhibited H3K37A cells.
Reduced TORC1 activity extends both chronological 
and replicative longevity in all organisms examined [40]. 
Because H3K37A increases TORC1 signaling, we spe-
cifically determined whether this histone mutant altered 
chronological longevity. Yeast chronological aging assays 
involve culturing cells in minimal (SC) media for 3 days 
(See figure on next page.) 
Fig. 6 HMG chromatin binding and TORC1 function to promote cell viability and longevity. a IB analysis for phosphoS6 levels from H3WT and 
H3K37A cells cultured to log phase and then either mock or 20 nM rapamycin treated for 30 min. b As in a except the indicated HMG gene dele-
tion mutants were included. c H3WT cells were transformed with control vector or the indicated galactose-regulated HMG expression vectors and 
cultured to log phase in raffinose media before induction with 2 % galactose for 20 min. Samples were then processed for phosphoS6 IB analysis. 
d–f As in c except cells were cultured solely in raffinose media to log phase and then stained with 5(6)-CFDA and analyzed by flow cytometry. e 
represents the average and SD of the peak 5(6)-CFDA fluorescence of the entire gated population, while f is the average cell number and SD of the 
fraction inside the bracket in d. Data are quantification of five independent experiments. g Chronological aging assay of H3WT and H3K37A per-
formed in non-buffered and buffered (buff ) SC media. Each strain was cultured in triplicate, and the data represent the average and SD of each time 
point performed in triplicate. For all statistical analyses, one-way ANOVA was performed across all categories (indicated by the dashed line), while 
the solid black lines indicate specific pairwise comparisons that were analyzed by Student’s t test. *P < 0.05; **P < 0.01; ***P < 005
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to exhaust nutrients. At this point, the experiment is ini-
tiated (Day 0) and quantification of cell survival by ana-
lyzing colony-forming units (CFUs) begins [41]. Our 
initial attempts following this approach resulted in too 
few viable H3K37A cells at Day 0, so we modified the 
experiment and only cultured cells for 1 day before initi-
ating the experiment. As media acidification can confuse 
interpretation of yeast aging studies [42], we performed 
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the experiments in media either non-buffered or buff-
ered to pH 6.0. Under non-buffered conditions, both 
H3WT and H3K37A exhibited decreased viability by 
Day 3, although H3K37A viability was reduced signifi-
cantly more than H3WT (Fig. 6g). Importantly, perform-
ing the experiment in buffered media prevented loss of 
H3WT viability over the course of the experiment, thus 
demonstrating that decreased H3WT viability under 
non-buffered conditions is due solely to acid stress and is 
not a true longevity defect (Fig. 6g). However, even under 
buffered conditions H3K37A viability was substantially 
reduced (by ~50  %), thus demonstrating a true reduc-
tion in chronological longevity independent of acid stress 
(Fig.  6g). Collectively, these data demonstrate that the 
histone H3N-terminus anchors HMGBs in the nucleus 
to maintain normal TORC1 regulation and promote 
cell viability. Impairing this process deregulates TORC1 
signaling and causes cytotoxicity under conditions that 
mimic nutrient limitation (rapamycin treatment) or 
reflect a nutrient-depleted state (chronological aging).
Discussion
While it is clear that responses to environmental change 
include epigenetic mechanisms that depend on dynamic 
chromatin regulation, how this information is faithfully 
transmitted to chromatin is not well understood. In this 
report, we provide critical evidence that the nutrient reg-
ulated TORC1 pathway, and the histone H3N-terminal 
tail at H3K37, function collaboratively to retain specific 
chromatin-associated HMGB factors within the nucleus 
to maintain cell viability. These data provide further sup-
port for the concept that signaling through TORC1 is a 
key mechanism by which the environment communi-
cates with chromatin to affect the epigenome. They also 
demonstrate an essential role for chromatin in restricting 
HMGBs to the nucleus that is required for maintaining 
viability in TORC1-suppressive environmental condi-
tions, including nutrient stress or during chronological 
aging. Our results support the idea that under conditions 
which severely repress TORC1, HMGB chromatin dis-
sociation and cytoplasmic localization may act as a cell 
death-initiating event. Conceptually, this idea is distinct 
from the current paradigm developed from studies in 
mammalian cells where release of HMGB1 from chro-
matin occurs after necrosis is initiated. This proposed 
function for chromatin also would be consistent with 
the growing recognition that chromatin modulation is 
not solely an endpoint for upstream signaling pathways. 
Instead, dynamic chromatin changes can integrate inputs 
from upstream signaling pathways and then propagate 
this information to control additional regulatory path-
ways to mediate biological effects. Therefore, TORC1 
signaling and downstream control of HMGB chromatin 
association may function as a bidirectional signaling relay 
to mediate control of cell viability under nutrient-regu-
lated conditions.
Our data further demonstrate that H3K37A selectively 
affects HMGB nuclear localization, thus illustrating that 
not all HMGBs are governed by the same chromatin-
interacting mechanisms. For example, we demonstrate 
that Ixr1 steady-state nuclear localization is perturbed 
by H3K37A when TORC1 is not inhibited, yet under 
these same conditions, Nhp6a is only minimally affected, 
while Hmo1 is not affected at all. However, this situa-
tion is reversed when TORC1 is inhibited, such that Ixr1 
becomes exclusively nuclear, while Nhp6a accumulates 
in the cytoplasm. These results, coupled with our previ-
ous observation that H3K37A decreases Nhp10 chro-
matin binding, suggest that in  vivo, H3K37 stabilizes 
specific HMGB interactions with chromatin. Such a 
scenario is consistent with the highly selective role for 
the histone H3N-terminal tail in contacting HMGB1 in 
in  vitro nucleosomal binding assays [21, 22]. This study 
further strengthens the concept that chromatin can dic-
tate HMGB association in vivo, an idea which had been 
suggested previously from genome-wide and gene-spe-
cific HMGB analyses [17, 43]. Because HMG proteins 
constitute the largest fraction of non-histone chromatin-
associated proteins, further defining the mechanisms 
governing their chromatin binding will be essential for 
understanding their role in genome regulation.
Additional mechanisms likely function in parallel with 
H3K37 to promote HMGB chromatin association and 
nuclear localization, including redundant interactions 
with the H3 tail, specific chromatin structures regulated 
by the local histone post-translational modification envi-
ronment, or even modification of the HMGBs directly. 
This latter point is especially relevant since HMGB1 is 
extensively modified by a variety of post-translational 
modifications including phosphorylation, acetyla-
tion, and oxidation [44, 45]. A distinct possibility is that 
TORC1 regulates HMGB modifications to facilitate 
their chromatin binding such that combining H3K37A 
with decreased TORC1 signaling synergistically impairs 
HMGB chromatin association and nuclear retention. 
H3K37 disruption, while selectively impacting HMGB 
nuclear localization, clearly has differential effects on 
these HMGBs. The mechanisms driving these differ-
ences are not immediately obvious but could be related 
to the distinct functions of each HMGB. For example, 
Ixr1 has a potential role as a stress response regulator 
since it functions both as a transcriptional activator and 
as repressor of many target genes involved in this pro-
cess [35]. Since TORC1 inhibition activates the environ-
mental stress response, TORC1 repression may restore 
Ixr1 nuclear localization in H3K37A by overriding the 
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inhibitory effect H3K37A has on Ixr1 chromatin bind-
ing [46]. While H3K37A minimally affects Nhp6a nuclear 
localization during normal growth, suppressing TORC1 
causes a fraction of Nhp6a to localize to the cytoplasm. 
How the majority of Nhp6a remains in the nucleus under 
these conditions is unclear. However, Nhp6a is an abun-
dant HMGB so a distinct possibility could be that the 
cytoplasmic Nhp6a pool in TORC1-inhibited H3K37A 
cells may derive from a normally “hyperdynamic” frac-
tion of genome-bound, FACT-independent Nhp6a. In 
environmental conditions that repress TORC1, chroma-
tin may anchor this hyperdynamic HMGB population in 
the nucleus to prevent its cytoplasmic localization and 
induction of cell death.
We believe that disrupted HMGB chromatin associa-
tion, and their consequent cytoplasmic localization, likely 
initiates cell death in TORC1-inhibited H3K37A cells. We 
base this conclusion on the following observations. The 
H3K37R mutation both restores Nhp6a nuclear locali-
zation and completely rescues growth when TORC1 is 
inhibited. Furthermore, significant cell death is only detect-
able after Nhp6a localizes to the cytoplasm, implying that 
HMGB movement to the cytoplasm occurs before cell 
death initiation. Supporting this concept, we and oth-
ers have demonstrated that increased HMGB expression 
causes cytotoxicity, although the underlying mechanisms 
were not defined [17, 47, 48]. We provide a more detailed 
understanding of this process by demonstrating that intra-
vacuolar pH dysregulation caused by TORC1 inhibition 
in H3K37A can be replicated in cells with wild-type chro-
matin solely through HMGB deregulation. Furthermore, 
buffering pH partially restores H3K37A growth under 
TORC1-suppressive conditions. These results demon-
strate that cytoplasmic HMGBs impair vacuole homeosta-
sis through unknown mechanisms to cause necrosis. The 
apoptosis we observed in TORC1-inhibited H3K37A cells 
is more difficult to interpret. Apoptosis clearly depends on 
functional mitochondria, although deletion of traditional 
apoptosis effectors is incapable of restoring growth to these 
cells. Although this could be due to the concurrent necro-
sis that occurs, H3K37A ρ° cells fail to grow under buffered 
conditions when TORC1 is inhibited. Therefore, suppress-
ing both apoptosis and pH-induced necrosis simultane-
ously is not sufficient to promote growth of H3K37A cells. 
We interpret these data to suggest that while mitochondrial 
dysfunction is responsible for the apoptosis in TORC1-
inhibited H3K37A, mitochondria provide additional meta-
bolic requirements necessary for cell growth when TORC1 
is impaired. Such a role for mitochondria would be consist-
ent with the upregulation of mitochondrial function when 
TORC1 is inhibited [49, 50].
Finally, the TORC1 dysregulation caused by H3K37A 
is suppressed by nhp6a∆ or nhp10∆, but not by hmo1∆. 
Nhp6a and Nhp10 are the two HMGBs whose cytoplasmic 
localization specifically increases when TORC1 activity 
is reduced, suggesting their movement to the cytoplasm 
contributes to TORC1 deregulation. Although the major-
ity of Nhp6a localizes to the nucleus in H3K37A before 
TORC1 suppression, it is possible that a small fraction 
exists in the cytoplasm which cannot be reliably detected. 
Furthermore, while we have not specifically addressed 
whether ixr1∆ suppresses the deregulated TORC1 signal-
ing in H3K37A, this HMGB likely does contribute since 
a significant fraction of it is cytoplasmic during normal 
H3K37A growth. An intriguing observation is that while 
Hmo1 localization is not affected by H3K37A, and hmo1∆ 
fails to reduce H3K37A TORC1 dysregulation, this HMGB 
is a key effector of the TORC1-regulated transcriptome 
[51]. Therefore, not all HMGBs linked to TORC1-regu-
lated transcription are impacted by H3K37A. The obser-
vation that multiple HMGBs are affected by H3K37A and 
contribute to TORC1 deregulation does provide an expla-
nation for why no single HMGB gene deletion restores 
viability to TORC1-inhibited H3K37A cells. The cytoplas-
mic accumulation of multiple HMGBs simultaneously is 
likely what induces cytotoxicity upon TORC1 suppression. 
How cytoplasmic HMGBs dysregulate TORC1 signaling, 
and this causes cell death when TORC1 activity is reduced, 
is not yet understood. Regardless of the mechanisms 
involved, our data outline a role for TORC1 and the H3N-
terminal tail in HMGB nuclear anchoring. This pathway is 
essential for cell survival when TORC1 activity is limiting, 
and it plays an important role in chronological aging. In 
metazoans, mechanisms that alter the H3N-terminus over 
time in post-mitotic cells may release nuclear HMGBs into 
the cytoplasm to limit their chronological longevity.
Conclusions
This study reveals a crucial role for H3K37 in the mainte-
nance of cell homeostasis and viability under conditions 
of reduced TORC1 signaling. Specifically, we demon-
strate that H3K37 disruption differentially effects the 
nuclear localization of a subset of HMGB proteins. Most 
importantly, we show that impaired TORC1 signaling in 
an H3K37 mutant increases the localization of the model 
HMGB, Nhp6a, and that this correlates with impaired 
organelle homeostasis and the induction of both apop-
tosis and necrosis. Intriguingly, while the apoptosis 
requires mitochondria, it does not depend on traditional 
apoptotic effectors. The resulting necrosis which occurs 
is connected to impaired vacuole homeostasis and pH 
dysregulation. Unexpectedly, our results directly show 
that H3K37 disruption increases basal TORC1 signal-
ing, an effect which is suppressed by deletion of the genes 
encoding those HMGBs whose cytoplasmic localization 
increases in an H3K37 mutant. This increased TORC1 
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signaling can be replicated in cells with normal chroma-
tin by overexpressing these same HMGBs, thus demon-
strating a direct role for HMGBs in TORC1 deregulation. 
The physiological consequence TORC1 deregulation 
is to severely reduce the chronological longevity of the 
H3K37 mutant, a result consistent with TORC1 as an 
essential aging regulator. HMG proteins are highly con-
served throughout evolution, and they constitute the 
most abundant protein component of chromatin outside 
of histones. Our results suggest the evolutionarily con-
served H3N-terminal tail likely anchors HMGBs in all 
eukaryotes as a mechanism of retaining them within the 
nucleus to maintain homeostasis, prevent TORC1 dereg-
ulation, and promote cellular longevity.
Methods
Yeast plasmids, strains, and culture conditions
Yeast strains and plasmids utilized are listed in Additional 
File 2: Table S1 and Table S2, respectively. Except for the 
histone H3 shuffle strain used in Fig.  1c, all other yeast 
histone mutants in this study were derived from the pub-
lished histone H3/H4 library [52] which was purchased 
from Open Biosystems (GE Dharmacon). To generate 
ura3∆ derivatives of the H3WT and H3K37A, cells were 
streaked to 5-FOA-containing plates and resistant clones, 
which had lost the ability to grow in the absence of uracil, 
were isolated. Yeast strain engineering, including gene dele-
tion or epitope tagging, was performed as described [53]. 
For experiments in nutrient-rich media, cells were cultured 
in 1 % yeast extract/2 % peptone/2 % dextrose (YPD) with 
media components purchased from Research Products 
International. Experiments in minimal media were per-
formed by culturing cells in yeast synthetic complete (SC) 
media (0.17 % yeast nitrogen base/0.1 % glutamic acid/2 % 
glucose/0.2 % dropout mix) or SC media lacking the appro-
priate nutrient. Yeast SC culture media reagents were pur-
chased from US Biologicals. To isolate H3WT and H3K37A 
ρ° mutants, cells were cultured in SC media containing 
25  mg/mL ethidium bromide and then individual colo-
nies were isolated. All ρ° mutants were confirmed to have 
lost functional mitochondria by their inability to grow on 
a non-fermentable (glycerol) carbon source. For the confo-
cal microscopy analysis experiments utilizing the TOR1-1 
expression vector, cells were cultured to mid-log phase in 
SC-leucine media that was buffered to pH 6.5 before treat-
ing with 20 nM rapamycin for two hours. All cells were cul-
tured at 30 °C with shaking. For spotting assays, equal cell 
numbers from overnight cultures were pelleted, washed, 
and then fivefold serially diluted. Cells were then spotted 
to the appropriate plates and incubated at 30 °C for four to 
six days before photographing. The H3K37A and H3K37R 
histone plasmids were generated via standard site-directed 
mutagenesis with plasmid pWZ414-F12 as a template [23]. 
To generate the high copy vector overexpressing SOD1, 
300 base pairs upstream of the translational start site and 
100 bp downstream of the translational stop of the SOD1 
genomic locus from yeast strain BY4741 were cloned as 
an XhoI/BamHI fragment into vector pRS426. Galactose-
regulated plasmids were purchased from Open Biosystems.
Antibodies and cell stains
The following antibodies were utilized: α-RPS6 (Abcam), 
α-phosphoS6 (Cell Signaling), α-HA and α-GFP (Santa 
Cruz), and α-G6PDH (Sigma). DNA staining of live cells 
was performed with Hoechst stain (Life Technologies). YO-
PRO-1 and PI stains were purchased from Life Technologies.
Live cell confocal microscopy
For the GFP localization experiments, cells were grown 
to log phase, pelleted, and washed twice with sterile 
water. Pellets were resuspended in 100  μL sterile water 
and stained with Hoechst 33342 (2 μg/mL) for 20–30 min 
prior to mounting onto polylysine-coated slides and con-
focal analysis. The vacuole pH experiments were con-
ducted similarly to the GFP localization experiments, 
except FM4-64 (8 μM) and CFDA (5 μM) were added to 
cells cultured in YPD.
Image analysis in Zen 2 blue
Zen Lite version 2.0.0 software was utilized to perform 
quantification of Nhp6a nuclear/cytoplasmic localiza-
tion. The Spline Contour tool was used to trace bor-
ders around the cell periphery and nucleus of individual 
cells. Borders were closed, and the fluorescence intensity 
within each enclosed area was calculated, along with the 
mean intensity value for each channel. The nuclear area 
was multiplied by the mean intensity value for the green 
channel to give the total nuclear fluorescence intensity 
(TNFI).
This was repeated using the outer cell border values 
which provided a measure of the total cellular fluores-
cence intensity (TCFI).
The following calculation was then performed to get 
the percentage of total nuclear protein:
Random fields of cells were chosen for quantification, 
with approximately 20–40 cells quantified per condi-
tion, per biological replicate (3 replicates). Only cells with 
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clear nuclear DNA staining and detectable EGFP signal 
were quantified.
Flow cytometry
For the YO-PRO-1 and PI staining, cells were grown to 
log phase, pelleted, and washed twice with sterile PBS. 
YO-PRO-1 (10 μM) and PI (50 μg/mL) were added fol-
lowed by a 20- to 30-min incubation. Samples were then 
processed on a BD LSRII flow cytometer, and data were 
analyzed using FlowJo V10. DHE (30 μM) and 5(6)-car-
boxyfluorescein diacetate (CFDA, 100  μM) staining 
were performed identically to that described above.
RT‑qPCR and immunoblot analysis
Total RNA was extracted, and randomly primed cDNA 
was synthesized using 1  μg of DNase I-digested RNA 
and the ImProm II Reverse Transcription System from 
Promega. Gene-specific qPCR and normalization to the 
SPT15 housekeeping gene were performed as previously 
described [54]. Whole-cell extracts and immunoblotting 
were prepared and performed as outlined previously [54]. 
To quantify immunoblot results, films were scanned and 
analyzed by ImageJ software.
Chronological aging assay
Single H3WT or H3K37A colonies were picked from 
freshly streaked YPD plates and cultured overnight in 
5 mL SC. The stationary phase cultures were then diluted 
into fresh SC media to an OD600 of 0.1 and returned to 
the incubator. This marked the beginning of the experi-
ment, denoted as “day 0.” Because the H3K37A viability 
declined so quickly, dilution and spotting were conducted 
every day for 6 days. For the buffered media, the 50-mL 
SC media used to age the cells were adjusted to pH 6.0 
using citrate phosphate buffer (64.2  mM Na2HPO4 and 
17.9 mM citric acid).
Additional files
Additional file 1. Figure S1. TORC1 inhibition does not alter Abf2 or 
Hmo1 cellular localization. H3WT and H3K37A cells expressing Abf2-EGFP 
(A) or Hmo1-EGFP (B) were mock or 20 nM rapamycin treated for one hour 
before performing confocal microscopy analysis. The nucleus is indicated 
by Hoechst (blue) staining and cell outlines are indicated by the line 
trace. Scale bar indicates 5 μm. Figure S2. Rapamycin-resistant TOR1-1 
expression restores nuclear Nhp6a localization in H3K37A. Nhp6a-EGFP 
expressing H3WT (A) or H3K37A (B) cells carrying control vector or the 
TOR1-1 expression vector were mock or 20 nM rapamycin treated for 
two hours before confocal microscopy analysis. The outline of individual 
cells is indicated by the line trace. Position of the nucleus is indicated by 
blue Hoechst staining. Arrows indicate Nhp6a at the nuclear periphery 
and cytoplasmic Nhp6a-EGFP signal. Scale bar indicates 5 μm. Figure 
S3. Brightfield images for Figure 3. A Brightfield images for Nhp6a-EGFP 
results presented in Figure 3A. B Brightfield images for the Sp16-EGFP data 
represented in Figure 3C. Scale bar indicated 5 μm.
Additional file 2. Table S1. Yeast strains. Table S2. Yeast plasmids.
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